Page 2 of 70Results 11 to 20 of 692, 18 July - 07 October 2025
-
New way to treat high blood pressure on the horizon thanks to funding award
A University of Aberdeen pre-spinout company will take the next 'crucial' step towards bringing a brand-new type of blood pressure medication to patients thanks to a funding award from the Scottish Funding Council.
-
Potential new therapeutic target for asthma discovered
A new way to treat asthma symptoms and even repair previously irreversible lung damage could be on the horizon following the discovery of a potential new therapeutic target by scientists at the University of Aberdeen.
-
University launches new course to inspire budding entrepreneurs
The University of Aberdeen has launched a new course to help students and staff turn their business ideas into reality.
-
AMEE Conference '25 - Barcelona
Professor Amudha Poobalan, Personal Chair (IAHS) - attendance at the AMEE conference.
-
Childhood trauma linked to mental health problems and chronic pain in later life
New research from the University of Aberdeen challenges the current view that trauma in childhood increases the risk of all health conditions. The study found instead that some conditions are more affected than others and women are more affected than men.
-
University of Aberdeen set to welcome thousands of visitors during its August Open Day
The University of Aberdeen is inviting prospective students to explore everything it has to offer at its upcoming Undergraduate Open Day on 26 August 2025.
-
Volunteers sought for brain study to investigate connections between autism and anorexia
Autistic individuals are at greater risk of developing anorexia, more likely to require in-patient treatment and respond less effectively to treatment for the eating disorder*.
-
University of Aberdeen launches new spin-out Brigid Bio
The University of Aberdeen today announces the launch of a new spin-out company developing novel immunotherapies to combat invasive fungal infections.
-
GLP1 weight loss injections may reduce asthma symptoms
GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people according to a new study from the University of Aberdeen and The Observational and Pragmatic Research Institute (OPRI), Singapore.
-
First student entrepreneurship Accelerator programme takes off
The University of Aberdeen has successfully completed its inaugural flagship student entrepreneurship programme, the Take Off Accelerator 2025, marking another milestone in its commitment to nurturing the next generation of innovators and changemakers.